Health-related quality of life in pre-pubertal children with pediatric growth hormone deficiency: 12-month results from a phase 3 clinical trial of once-weekly somatrogon versus once-daily somatropin

References

• Rothermel J, Reinehr T. Metabolic alterations in paediatric GH deficiency. Best Pract Res Clin Endocrinol Metab. 2016;30(6):757–770. doi:10.1016/j.beem.2016.11.004.
   PubMed Web of Science ®Google Scholar
• Bullinger M, Kołtowska-Häggström M, Sandberg D, et al. Health-Related quality of life of children and adolescents with growth hormone deficiency or idiopathic short stature – part 2: available results and future directions. Horm Res. 2009;72(2):74–81. doi:10.1159/000232159.
   PubMedGoogle Scholar
• Backeljauw P, Cappa M, Kiess W, et al. Impact of short stature on quality of life: a systematic literature review. Growth Horm IGF Res. 2021;57-58:101392. doi:10.1016/j.ghir.2021.101392.
   PubMed Web of Science ®Google Scholar
• Brod M, Alolga SL, Beck JF, et al. Understanding burden of illness for child growth hormone deficiency. Qual Life Res. 2017;26(7):1673–1686. doi:10.1007/s11136-017-1529-1.
   PubMed Web of Science ®Google Scholar
• Maghnie M, Orso M, Polistena B, et al. Quality of life in children and adolescents with growth hormone deficiency and their caregivers: an Italian survey. J Endocrinol Invest. 2023;46(12):2513–2523. May 20. doi:10.1007/s40618-023-02106-3.
   PubMedGoogle Scholar
• Reh CS, Geffner ME. Somatotropin in the treatment of growth hormone deficiency and turner syndrome in pediatric patients: a review. Clin Pharmacol. 2010;2:111–122. doi:10.2147/CPAA.S6525.
   PubMedGoogle Scholar
• González Briceño LG, Viaud M, Beltrand J, et al. Improved general and height-specific quality of life in children with short stature after 1 year on growth hormone. J Clin Endocrinol Metab. 2019;104(6):2103–2111. doi:10.1210/jc.2018-02523.
   PubMed Web of Science ®Google Scholar
• Quitmann J, Bloemeke J, Silva N, et al. Quality of life of short-Statured children born small for gestational age or idiopathic growth hormone deficiency within 1 year of growth hormone treatment. Front Pediatr. 2019;7:164. doi:10.3389/fped.2019.00164.
   PubMed Web of Science ®Google Scholar
• Sultan S, El-Hourani M, Rondeau E, et al. Categorizing factors of adherence to parenteral treatment in growth hormone deficiencies and hemophilia: what should be the targets for future research? Patient Prefer Adherence. 2018;12:2039–2063. doi:10.2147/PPA.S177624.
   PubMed Web of Science ®Google Scholar
• Graham S, Weinman J, Auyeung V. Identifying potentially modifiable factors associated with treatment non-adherence in paediatric growth hormone deficiency: a systematic review. Horm Res Paediatr. 2018;90(4):221–227. doi:10.1159/000493211.
   PubMed Web of Science ®Google Scholar
• Loftus J, Chen Y, Alvir JMJ, et al. Suboptimal adherence to daily growth hormone in a US real-world study: an unmet need in the treatment of pediatric growth hormone deficiency. Curr Med Res Opin. 2021;37(12):2141–2150. doi:10.1080/03007995.2021.1982682.
   PubMed Web of Science ®Google Scholar
• Koledova E, Stoyanov G, Ovbude L, et al. Adherence and long-term growth outcomes: results from the easypodTM connect observational study (ECOS) in paediatric patients with growth disorders. Endocr Connect. 2018;7(8):914–923. doi:10.1530/EC-18-0172.
   PubMed Web of Science ®Google Scholar
• Farfel A, Shalitin S, Morag N, et al. Long-term adherence to growth hormone therapy in a large health maintenance organization cohort. Growth Horm IGF Res. 2019;44:1–5. doi:10.1016/j.ghir.2018.10.004.
   PubMed Web of Science ®Google Scholar
• Loftus J, Wogen J, Oliveri D, et al. Persistence with daily growth hormone among children and adolescents with growth hormone deficiency in the UK. Front Endocrinol (Lausanne). 2022;13:1014743. doi:10.3389/fendo.2022.1014743.
   PubMed Web of Science ®Google Scholar
• Cutfield WS, Derraik JG, Gunn AJ, et al. Non-compliance with growth hormone treatment in children is common and impairs linear growth. PLoS One. 2011;6(1):e16223. doi:10.1371/journal.pone.0016223.
   PubMed Web of Science ®Google Scholar
• Loftus J, Miller BS, Parzynski CS, et al. Association of daily growth hormone injection adherence and height among children with growth hormone deficiency. Endocr Pract. 2022;28(6):565–571. doi:10.1016/j.eprac.2022.02.013.
   PubMed Web of Science ®Google Scholar
• Graham S, Auyeung V, Weinman J. Exploring potentially modifiable factors that influence treatment non-adherence amongst pediatric growth hormone deficiency: a qualitative study. Patient Prefer Adherence. 2020;14:1889–1899. doi:10.2147/PPA.S268972.
   PubMed Web of Science ®Google Scholar
• Fisher BG, Acerini CL. Understanding the growth hormone therapy adherence paradigm: a systematic review. Horm Res Paediatr. 2013;79(4):189–196. doi:10.1159/000350251.
   PubMed Web of Science ®Google Scholar
• Kremidas D, Wisniewski T, Divino VM, et al. Administration burden associated with recombinant human growth hormone treatment: perspectives of patients and caregivers. J Pediatr Nurs. 2013;28(1):55–63. doi:10.1016/j.pedn.2011.12.006.
   PubMed Web of Science ®Google Scholar
• Brod M, Hojbjerre L, Alolga SL, et al. Understanding treatment burden for children treated for growth hormone deficiency. Patient. 2017;10(5):653–666. doi:10.1007/s40271-017-0237-9.
   PubMedGoogle Scholar
• Bagnasco F, Di Iorgi N, Roveda A, et al. Prevalence and correlates of adherence in children and adolescents treated with growth hormone: a multicenter Italian study. Endocr Pract. 2017;23(8):929–941. doi:10.4158/EP171786.OR.
   PubMed Web of Science ®Google Scholar
• McNamara M, Turner-Bowker DM, Westhead H, et al. Factors driving patient preferences for growth hormone deficiency (GHD) injection regimen and injection device features: a discrete choice experiment. Patient Prefer Adherence. 2020;14:781–793. doi:10.2147/PPA.S239196.
   PubMed Web of Science ®Google Scholar
• Loftus J, Yaworsky A, Roland CL, et al. Experience of switching from a daily to a less frequent administration of injection treatments. PLoS One. 2022;17(11):e0278293. doi:10.1371/journal.pone.0278293.
   PubMed Web of Science ®Google Scholar
• Mameli C, Orso M, Calcaterra V, et al. Efficacy, safety, quality of life, adherence and cost-effectiveness of long-acting growth hormone replacement therapy compared to daily growth hormone in children with growth hormone deficiency: a systematic review and meta-analysis. Pharmacol Res. 2023;193:106805. doi:10.1016/j.phrs.2023.106805.
   PubMed Web of Science ®Google Scholar
• Zelinska N, Iotova V, Skorodok J, et al. Long-acting C-terminal peptide-modified hGH (MOD-4023): results of a safety and dose-finding study in GHD children. J Clin Endocrinol Metab. 2017;102(5):1578–1587. doi:10.1210/jc.2016-3547.
   PubMed Web of Science ®Google Scholar
• Deal CL, Steelman J, Vlachopapadopoulou E, et al. Efficacy and safety of weekly somatrogon vs daily somatropin in children with growth hormone deficiency: a phase 3 study. J Clin Endocrinol Metab. 2022;107(7):e2717–e2728. doi:10.1210/clinem/dgac220.
   PubMed Web of Science ®Google Scholar
• Bullinger M, Quitmann J, Power M, et al. Assessing the quality of life of health-referred children and adolescents with short stature: development and psychometric testing of the QoLISSY instrument. Health Qual Life Outcomes. 2013;11(1):76. doi:10.1186/1477-7525-11-76.
   PubMedGoogle Scholar
• U.S. Food and Drug Administration. Guidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claims. 2009 [cited 2023 Jul 27]. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/patient-reported-outcome-measures-use-medical-product-development-support-labeling-claims
   Google Scholar
• Quitmann J, Rohenkohl A, Bullinger M, et al. Parental perception of health-related quality of life in children and adolescents with short stature: literature review and introduction of the parent-reported QoLISSY instrument. PER. 2013;11(2):147–160.
   Google Scholar
• Bloemeke J, Silva N, Bullinger M, et al. Psychometric properties of the quality of life in short statured youth (QoLISSY) questionnaire within the course of growth hormone treatment. Health Qual Life Outcomes. 2019;17(1):49. doi:10.1186/s12955-019-1118-9.
   PubMedGoogle Scholar
• Wild D, Grove A, Martin M, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health. 2005;8(2):94–104. doi:10.1111/j.1524-4733.2005.04054.x.
   PubMed Web of Science ®Google Scholar
• Drosatou C, Vlachopapadopoulou EA, Bullinger M, et al. Validation of the greek version of the quality of life in short stature youth (QoLISSY) questionnaire. J Pediatr Endocrinol Metab. 2019;32(3):215–224. doi:10.1515/jpem-2018-0403.
   PubMed Web of Science ®Google Scholar
• Bloemeke J, Balacano Valdez R, Mauras N, et al. Psychometric performance of the quality of life in short stature youth (QoLISSY) questionnaire in a randomized open-label comparator trial in idiopathic short stature. J Pediatr Endocrinol Metab. 2019;32(10):1089–1101. doi:10.1515/jpem-2019-0137.
   PubMed Web of Science ®Google Scholar
• Bullinger M, Bloemeke J, Mericq V, et al. Quality of life in adolescent boys with idiopathic short stature: Positive impact of growth hormone and aromatase inhibitors. Horm Res Paediatr. 2018;90(6):381–392. doi:10.1159/000496353.
   PubMed Web of Science ®Google Scholar
• Maniatis AK, Carakushansky M, Galcheva S, et al. Treatment burden of weekly somatrogon vs daily somatropin in children with growth hormone deficiency: a randomized study. J Endocr Soc. 2022;6(10):bvac117. doi:10.1210/jendso/bvac117.
   PubMed Web of Science ®Google Scholar
• Quitmann J, Rohenkohl A, Sommer R, et al. Explaining parent-child (dis)agreement in generic and short stature-specific health-related quality of life reports: do family and social relationships matter? Health Qual Life Outcomes. 2016;14(1):150. doi:10.1186/s12955-016-0553-0.
   PubMedGoogle Scholar
• Hall CA, Donza C, McGinn S, et al. Health-Related quality of life in children with chronic illness compared to parents: a systematic review. Pediatr Phys Ther. 2019;31(4):315–322. doi:10.1097/PEP.0000000000000638.
   PubMed Web of Science ®Google Scholar
• Revicki D, Hays RD, Cella D, et al. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol. 2008;61(2):102–109. doi:10.1016/j.jclinepi.2007.03.012.
   PubMed Web of Science ®Google Scholar
• Cappelleri JC, Bushmakin AG. Interpretation of patient-reported outcomes. Stat Methods Med Res. 2014;23(5):460–483. doi:10.1177/0962280213476377.
   PubMed Web of Science ®Google Scholar
• Lackner L, Quitmann JH, Witt S. Caregiving burden and special needs of parents in the care of their short-statured children – a qualitative approach. Front Endocrinol (Lausanne). 2023;14:1093983. doi:10.3389/fendo.2023.1093983.
   PubMed Web of Science ®Google Scholar